Pathophysiology of COVID-19: Why Children Fare Better than Adults?

Abstract The world is facing Coronavirus Disease-2019 (COVID-19) pandemic, which is causing a large number of deaths and burden on intensive care facilities. It is caused by Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2) originating in Wuhan, China. It has been seen that fewer children contract COVID-19 and among infected, children have less severe disease. Insights in pathophysiological mechanisms of less severity in children could be important for devising therapeutics for high-risk adults and elderly. Early closing of schools and day-care centers led to less frequent exposure and hence, lower infection rate in children. The expression of primary target receptor for SARS-CoV-2, i.e. angiotensin converting enzyme-2 (ACE-2), decreases with age. ACE-2 has lung protective effects by limiting angiotensin-2 mediated pulmonary capillary leak and inflammation. Severe COVID-19 disease is associated with high and persistent viral loads in adults. Children have strong innate immune response due to trained immunity (secondary to live-vaccines and frequent viral infections), leading to probably early control of infection at the site of entry. Adult patients show suppressed adaptive immunity and dysfunctional over-active innate immune response in severe infections, which is not seen in children. These could be related to immune-senescence in elderly. Excellent regeneration capacity of pediatric alveolar epithelium may be contributing to early recovery from COVID-19. Children, less frequently, have risk factors such as co-morbidities, smoking, and obesity. But young infants and children with pre-existing illnesses could be high risk groups and need careful monitoring. Studies describing immune-pathogenesis in COVID-19 are lacking in children and need urgent attention..

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:87

Enthalten in:

Indian journal of pediatrics - 87(2020), 7 vom: 14. Mai, Seite 537-546

Sprache:

Englisch

Beteiligte Personen:

Dhochak, Nitin [VerfasserIn]
Singhal, Tanu [VerfasserIn]
Kabra, S. K. [VerfasserIn]
Lodha, Rakesh [VerfasserIn]

Links:

Volltext [lizenzpflichtig]

BKL:

44.67

Themen:

ACE-2
Adaptive immunity
Innate immunity
Pathogenesis
SARS-CoV2

doi:

10.1007/s12098-020-03322-y

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

SPR04013900X